Leading with impact to revitalise a European pharma business that’s taking the fight to cancer, via cutting-edge, low toxicity treatments — to spread hope, extend healthspans and change lives.
iOnctura

Revolutionising a future-focused biotech business

Services

  • Brand strategy
  • Brand identity
  • Corporate website
  • Moving image
  • Corporate presentation
Leading with impact to revitalise a European pharma business that’s taking the fight to cancer, via cutting-edge, low toxicity treatments — to spread hope, extend healthspans and change lives.

Leading with impact to revitalise a European pharma business that’s taking the fight to cancer, via cutting-edge, low toxicity treatments — to spread hope, extend healthspans and change lives.

Awards
Digital Impact Awards: Best use of digital from the healthcare & pharma sector — Bronze
Digital Impact Awards: Best digital rebrand — Highly commended
Corporate & Financial Awards: Best corporate website (unlisted) — Shortlisted (awaiting results)
Leading with impact to revitalise a European pharma business that’s taking the fight to cancer, via cutting-edge, low toxicity treatments — to spread hope, extend healthspans and change lives.
Leading with impact to revitalise a European pharma business that’s taking the fight to cancer, via cutting-edge, low toxicity treatments — to spread hope, extend healthspans and change lives.
Leading with impact to revitalise a European pharma business that’s taking the fight to cancer, via cutting-edge, low toxicity treatments — to spread hope, extend healthspans and change lives.
Leading with impact to revitalise a European pharma business that’s taking the fight to cancer, via cutting-edge, low toxicity treatments — to spread hope, extend healthspans and change lives.

What they said

The team at 330 did an amazing job with our branding and messaging. I never believed a brand could truly embody a company's culture, ambitions, and strategy all at once — but they made it happen!
Catherine Pickering
CEO
Leading with impact to revitalise a European pharma business that’s taking the fight to cancer, via cutting-edge, low toxicity treatments — to spread hope, extend healthspans and change lives.
Leading with impact to revitalise a European pharma business that’s taking the fight to cancer, via cutting-edge, low toxicity treatments — to spread hope, extend healthspans and change lives.
Leading with impact to revitalise a European pharma business that’s taking the fight to cancer, via cutting-edge, low toxicity treatments — to spread hope, extend healthspans and change lives.
Leading with impact to revitalise a European pharma business that’s taking the fight to cancer, via cutting-edge, low toxicity treatments — to spread hope, extend healthspans and change lives.
Leading with impact to revitalise a European pharma business that’s taking the fight to cancer, via cutting-edge, low toxicity treatments — to spread hope, extend healthspans and change lives.
Leading with impact to revitalise a European pharma business that’s taking the fight to cancer, via cutting-edge, low toxicity treatments — to spread hope, extend healthspans and change lives.
Leading with impact to revitalise a European pharma business that’s taking the fight to cancer, via cutting-edge, low toxicity treatments — to spread hope, extend healthspans and change lives.
Leading with impact to revitalise a European pharma business that’s taking the fight to cancer, via cutting-edge, low toxicity treatments — to spread hope, extend healthspans and change lives.
Leading with impact to revitalise a European pharma business that’s taking the fight to cancer, via cutting-edge, low toxicity treatments — to spread hope, extend healthspans and change lives.
Leading with impact to revitalise a European pharma business that’s taking the fight to cancer, via cutting-edge, low toxicity treatments — to spread hope, extend healthspans and change lives.
Leading with impact to revitalise a European pharma business that’s taking the fight to cancer, via cutting-edge, low toxicity treatments — to spread hope, extend healthspans and change lives.
Leading with impact to revitalise a European pharma business that’s taking the fight to cancer, via cutting-edge, low toxicity treatments — to spread hope, extend healthspans and change lives.
Leading with impact to revitalise a European pharma business that’s taking the fight to cancer, via cutting-edge, low toxicity treatments — to spread hope, extend healthspans and change lives.